Oxaliplatin
Colonic Neoplasms, Colorectal Carcinoma, Colorectal Neoplasms
Treatment
6 FDA approvals
1 Active Study for Oxaliplatin
Treatment for
Colonic Neoplasms
What is Oxaliplatin
Oxaliplatin
The Generic name of this drug
Treatment Summary
Oxaliplatin is a chemotherapy drug used to treat certain types of cancer, most commonly colorectal cancer. It is usually given in combination with two other drugs, fluorouracil and leucovorin, which are known as Folfox. Oxaliplatin is a form of platinum-based chemotherapy, similar to cisplatin and carboplatin, but it has been improved with cyclohexyldiamine to increase its effectiveness against tumors. The oxalato bidentate derived from oxalic acid is used to improve its water solubility. Oxaliplatin is sold under the
Eloxatin
is the brand name
Oxaliplatin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Eloxatin
Oxaliplatin
2002
91
Approved as Treatment by the FDA
Oxaliplatin, otherwise called Eloxatin, is approved by the FDA for 6 uses including Colorectal Carcinoma and Colorectal Neoplasms .
Colorectal Carcinoma
Used to treat Advanced Colorectal Cancer in combination with Fluorouracil
Colorectal Neoplasms
Used to treat Surgical Resection of the Colorectal Tumor in combination with Fluorouracil
Advanced Colorectal Cancer
Used to treat Advanced Colorectal Cancer in combination with Fluorouracil
Stage III Colon Cancer
Used to treat Stage III Colon Cancer in combination with Fluorouracil
Surgical Resection of the Colorectal Tumor
Used to treat Surgical Resection of the Colorectal Tumor in combination with Fluorouracil
Colonic Neoplasms
Used to treat Stage III Colon Cancer in combination with Fluorouracil
Effectiveness
How Oxaliplatin Affects Patients
Oxaliplatin stops the cells in your body from making DNA. It also stops them from making the proteins and RNA they need to function. The more of the drug that is taken, the more it affects the cells in your body.
How Oxaliplatin works in the body
Oxaliplatin works by stopping DNA from being made and copied. It does this by changing the chemical structure of the drug and then binding itself to the guanine and cytosine molecules in the DNA. This cross-linking of the DNA makes it impossible for it to be copied and prevents further cell growth. This process is not related to any specific stage in the cell cycle, and so it affects all cells equally.
When to interrupt dosage
The prescribed dosage of Oxaliplatin is contingent upon the diagnosed malady, including Stage III Colon Cancer, Colorectal Carcinoma and Colorectal Neoplasms. The measure of dosage shifts, depending on the technique of delivery as outlined in the table below.
Condition
Dosage
Administration
Colorectal Carcinoma
5.0 mg/mL, , 10.0 mg/mL, 50.0 mg, 100.0 mg, 20.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL
, Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Powder, for solution - Intravenous, Powder, for solution, Injection, solution - Intravenous, Injection, solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Solution, concentrate - Intravenous, Solution, concentrate
Colonic Neoplasms
5.0 mg/mL, , 10.0 mg/mL, 50.0 mg, 100.0 mg, 20.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL
, Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Powder, for solution - Intravenous, Powder, for solution, Injection, solution - Intravenous, Injection, solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Solution, concentrate - Intravenous, Solution, concentrate
Colorectal Neoplasms
5.0 mg/mL, , 10.0 mg/mL, 50.0 mg, 100.0 mg, 20.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL
, Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Powder, for solution - Intravenous, Powder, for solution, Injection, solution - Intravenous, Injection, solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Solution, concentrate - Intravenous, Solution, concentrate
Warnings
Oxaliplatin Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Oxaliplatin.
Common Oxaliplatin Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abatacept.
Abetimus
Major
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abetimus.
Acteoside
Major
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Acteoside.
Oxaliplatin Toxicity & Overdose Risk
There have been a few reported cases of oxaliplatin overdose. One patient received two doses within 24 hours (total of 260mg/m<sup>2</sup>) and suffered from low platelet count (below 25,000/mm<sup>3</sup>) without any bleeding. In two other cases, patients were given oxaliplatin instead of carboplatin, one received 500mg and the other received 650mg. Symptoms included difficulty breathing, wheezing, tingling or numbness, vomiting, and chest pain. The patient given 500mg went into respiratory failure and severe bradycardia,
Oxaliplatin Novel Uses: Which Conditions Have a Clinical Trial Featuring Oxaliplatin?
Five active trials are evaluating the potential of Oxaliplatin to combat Colorectal Neoplasms, Stage III Colon Cancer and Colorectal Carcinoma.
Condition
Clinical Trials
Trial Phases
Colonic Neoplasms
1 Actively Recruiting
Not Applicable
Colorectal Neoplasms
0 Actively Recruiting
Colorectal Carcinoma
0 Actively Recruiting
Oxaliplatin Reviews: What are patients saying about Oxaliplatin?
5
Patient Review
1/2/2014
Oxaliplatin for Colon and Rectal Cancer that has Spread to Another Area
4.7
Patient Review
1/24/2013
Oxaliplatin for Lymph Node Positive Colon Cancer
4.7
Patient Review
5/11/2013
Oxaliplatin for Colon and Rectal Cancer that has Spread to Another Area
4
Patient Review
10/12/2009
Oxaliplatin for Lymph Node Positive Colon Cancer
4
Patient Review
5/25/2012
Oxaliplatin for Colon and Rectal Cancer that has Spread to Another Area
3.7
Patient Review
8/1/2011
Oxaliplatin for Colon and Rectal Cancer that has Spread to Another Area
3.7
Patient Review
1/28/2019
Oxaliplatin for Lymph Node Positive Colon Cancer
3.7
Patient Review
7/8/2010
Oxaliplatin for Cancer of Large Intestine
3.3
Patient Review
6/27/2011
Oxaliplatin for Cancer of Large Intestine
3.3
Patient Review
10/31/2009
Oxaliplatin for Cancer of Large Intestine
3
Patient Review
12/3/2015
Oxaliplatin for Lymph Node Positive Colon Cancer
2.7
Patient Review
6/21/2011
Oxaliplatin for Lymph Node Positive Colon Cancer
2.3
Patient Review
3/22/2009
Oxaliplatin for Cancer of Large Intestine
2
Patient Review
11/26/2016
Oxaliplatin for Lymph Node Positive Colon Cancer
2
Patient Review
7/11/2009
Oxaliplatin for Colon and Rectal Cancer that has Spread to Another Area
1.7
Patient Review
5/27/2010
Oxaliplatin for Cancer of Large Intestine
1.7
Patient Review
2/28/2010
Oxaliplatin for Lymph Node Positive Colon Cancer
1.7
Patient Review
3/2/2011
Oxaliplatin for Lymph Node Positive Colon Cancer
Patient Q&A Section about oxaliplatin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How effective is oxaliplatin?
"The study found that the introduction of oxaliplatin had no significant effect on the three-year disease-free survival rate or the five-year overall survival rate."
Answered by AI
What are side effects of oxaliplatin?
"If you experience any of the following symptoms, contact your doctor:
Diarrhea, changes in taste, mouth sores, nosebleeds, tiredness, headache, dizziness, difficulty sleeping, nausea, or vomiting. Medication may be prescribed to prevent or relieve nausea and vomiting."
Answered by AI
Does oxaliplatin cause hair loss?
"During cancer treatment, it is common to lose some or all hair on your head, as well as facial and body hair. This typically occurs 3-4 weeks after treatment begins. To prepare for this, many people choose to buy a wig before hair loss begins. Hair loss is not permanent, and hair typically begins to grow back during treatment."
Answered by AI
Is oxaliplatin a strong chemo?
"Oxaliplatin is known to be the most toxic chemotherapy when it comes to nerve damage, and is the root cause of many peripheral neuropathies. These neuropathies can be a serious problem for cancer patients as there is no effective prevention strategy and the only known treatment, duloxetine, only seems to help improve symptoms."
Answered by AI